CD44 and nonpapillary renal cell carcinoma: Lee et al. [26], who examined a total of 107 ccRCCs and 32 non-ccRCCs, showed in univariate and multivariate analyses that increased CD44 expression was an independent predictor of shorter OS only in the ccRCC group.